143 related articles for article (PubMed ID: 37333273)
21. Human SLC46A2 Is the Dominant cGAMP Importer in Extracellular cGAMP-Sensing Macrophages and Monocytes.
Cordova AF; Ritchie C; Böhnert V; Li L
ACS Cent Sci; 2021 Jun; 7(6):1073-1088. PubMed ID: 34235268
[TBL] [Abstract][Full Text] [Related]
22. Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs.
Li L; Yin Q; Kuss P; Maliga Z; Millán JL; Wu H; Mitchison TJ
Nat Chem Biol; 2014 Dec; 10(12):1043-8. PubMed ID: 25344812
[TBL] [Abstract][Full Text] [Related]
23. Development of cGAMP-Luc, a sensitive and precise coupled enzyme assay to measure cGAMP in complex biological samples.
Mardjuki RE; Carozza JA; Li L
J Biol Chem; 2020 Apr; 295(15):4881-4892. PubMed ID: 32127400
[TBL] [Abstract][Full Text] [Related]
24. Encapsulation of STING Agonist cGAMP with Folic Acid-Conjugated Liposomes Significantly Enhances Antitumor Pharmacodynamic Effect.
Lu X; Cheng H; Xu Q; Tan X
Cancer Biother Radiopharm; 2023 Oct; 38(8):543-557. PubMed ID: 33719535
[No Abstract] [Full Text] [Related]
25. Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.
Wehbe M; Wang-Bishop L; Becker KW; Shae D; Baljon JJ; He X; Christov P; Boyd KL; Balko JM; Wilson JT
J Control Release; 2021 Feb; 330():1118-1129. PubMed ID: 33189789
[TBL] [Abstract][Full Text] [Related]
26. Anti-triple-negative breast cancer metastasis efficacy and molecular mechanism of the STING agonist for innate immune pathway.
Lu X; Wang X; Cheng H; Wang X; Liu C; Tan X
Ann Med; 2023 Dec; 55(1):2210845. PubMed ID: 37162544
[TBL] [Abstract][Full Text] [Related]
27. An alternatively spliced STING isoform localizes in the cytoplasmic membrane and directly senses extracellular cGAMP.
Li X; Zhu Y; Zhang X; An X; Weng M; Shi J; Wang S; Liu C; Luo S; Zheng T
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34905508
[TBL] [Abstract][Full Text] [Related]
28. Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): Synthesis, transmission, and degradation.
Su M; Zheng J; Gan L; Zhao Y; Fu Y; Chen Q
Biochem Pharmacol; 2022 Apr; 198():114934. PubMed ID: 35104477
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context.
Czapla J; Drzyzga A; Matuszczak S; Cichoń T; Rusin M; Jarosz-Biej M; Pilny E; Smolarczyk R
Front Oncol; 2023; 13():1249524. PubMed ID: 37655095
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation studies of novel small molecule ENPP1 inhibitors for cancer immunotherapy.
Gangar M; Goyal S; Raykar D; Khurana P; Martis AM; Goswami A; Ghoshal I; Patel KV; Nagare Y; Raikar S; Mukherjee A; Cyriac R; Paquin JF; Kulkarni A
Bioorg Chem; 2022 Feb; 119():105549. PubMed ID: 34929517
[TBL] [Abstract][Full Text] [Related]
31. ENPP1, an Old Enzyme with New Functions, and Small Molecule Inhibitors-A STING in the Tale of ENPP1.
Onyedibe KI; Wang M; Sintim HO
Molecules; 2019 Nov; 24(22):. PubMed ID: 31752288
[TBL] [Abstract][Full Text] [Related]
32. ENPP1 Immunobiology as a Therapeutic Target.
Ruiz-Fernández de Córdoba B; Martínez-Monge R; Lecanda F
Clin Cancer Res; 2023 Jun; 29(12):2184-2193. PubMed ID: 36719675
[TBL] [Abstract][Full Text] [Related]
33. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.
Cheng N; Watkins-Schulz R; Junkins RD; David CN; Johnson BM; Montgomery SA; Peine KJ; Darr DB; Yuan H; McKinnon KP; Liu Q; Miao L; Huang L; Bachelder EM; Ainslie KM; Ting JP
JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429378
[TBL] [Abstract][Full Text] [Related]
34. Discovery of Podofilox as a Potent cGAMP-STING Signaling Enhancer with Antitumor Activity.
Han J; Hu S; Hu Y; Xu Y; Hou Y; Yang Y; Su H; Zhang Z; Liu P; Sun X; Zhang C
Cancer Immunol Res; 2023 May; 11(5):583-599. PubMed ID: 36921097
[TBL] [Abstract][Full Text] [Related]
35. Metformin activates the STING/IRF3/IFN-β pathway by inhibiting AKT phosphorylation in pancreatic cancer.
Ren D; Qin G; Zhao J; Sun Y; Zhang B; Li D; Wang B; Jin X; Wu H
Am J Cancer Res; 2020; 10(9):2851-2864. PubMed ID: 33042621
[TBL] [Abstract][Full Text] [Related]
36. Arabinose- and xylose-modified analogs of 2',3'-cGAMP act as STING agonists.
Xie W; Lama L; Yang X; Kuryavyi V; Bhattacharya S; Nudelman I; Yang G; Ouerfelli O; Glickman JF; Jones RA; Tuschl T; Patel DJ
Cell Chem Biol; 2023 Nov; 30(11):1366-1376.e7. PubMed ID: 37536341
[TBL] [Abstract][Full Text] [Related]
37. Structural insights into cGAMP degradation by Ecto-nucleotide pyrophosphatase phosphodiesterase 1.
Kato K; Nishimasu H; Oikawa D; Hirano S; Hirano H; Kasuya G; Ishitani R; Tokunaga F; Nureki O
Nat Commun; 2018 Oct; 9(1):4424. PubMed ID: 30356045
[TBL] [Abstract][Full Text] [Related]
38. The lipid platform increases the activity of STING agonists to synergize checkpoint blockade therapy against melanoma.
Li K; Ye Y; Liu L; Sha Q; Wang X; Jiao T; Zhang L; Wang J
Biomater Sci; 2021 Feb; 9(3):765-773. PubMed ID: 33201161
[TBL] [Abstract][Full Text] [Related]
39. LL-37 transports immunoreactive cGAMP to activate STING signaling and enhance interferon-mediated host antiviral immunity.
Wei X; Zhang L; Yang Y; Hou Y; Xu Y; Wang Z; Su H; Han F; Han J; Liu P; Hu S; Koci MD; Sun X; Zhang C
Cell Rep; 2022 May; 39(9):110880. PubMed ID: 35649354
[TBL] [Abstract][Full Text] [Related]
40. ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP.
Maltbaek JH; Cambier S; Snyder JM; Stetson DB
Immunity; 2022 Oct; 55(10):1799-1812.e4. PubMed ID: 36070769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
